相关实验视频
Updated: Jan 23, 2026

07:34
FISH for Pre-implantation Genetic Diagnosis
Published on: February 23, 2011
37.8K
由于RBM20变异的早期心力衰竭:一个案例报告强调遗传诊断和不律性风险分层
Cristian Orlando Porras Bueno1, Cesar Augusto Balaguera1, Alejandro Mariño Correa1,2
1Departamento de Medicina Interna Pontificia Universidad Javeriana Bogotá Colombia.
Clinical case reports
|January 22, 2026
概括
在RBM20基因的遗传变异导致家族扩展性心肌病 (DCM) 和心力衰竭. 基因检测有助于早期诊断和个性化治疗RBM20心肌病患者及其家属.
科学领域:
- 遗传学 遗传学是一种遗传学.
- 心脏病学 心脏病学
- 分子生物学分子生物学
背景情况:
- RBM20基因编码了一种对心脏基因拼接至关重要的蛋白质.
- 致病性RBM20变体与家族扩展性心肌病 (DCM),心力衰竭和心脏突然死亡有关.
研究的目的:
- 报告一种由新型RBM20变种引起的DCM病例.
- 强调基因测试在诊断DCM和识别有风险的亲属方面的重要性.
主要方法:
- 对患有心力衰竭和射率降低的患者进行临床评估.
- 用于识别RBM20变种的基因检测 (c.1907G>A; p.Arg636His).
- 家庭查以确认遗传传输.
主要成果:
- 一名23岁的男性被诊断患有DCM,原因是异合的RBM20误解变体.
- 在他无症状的母亲和DCM受影响的妹妹中发现的相同变种.
- 患者接受了指导方针导向的治疗和转诊用于植入式心脏转换器-除器.
结论:
- 对于患有非缺血性心肌病的年轻患者来说,基因检测至关重要.
- 早期识别有风险的家庭成员可以实现个性化管理.
- 反感性寡核酸治疗和基因编辑显示了未来RBM20心肌病治疗的潜力.
相关概念视频
Heart Failure II: Pathophysiology
790
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
790
Pathophysiology of Heart Failure
3.0K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.0K
Heart Failure I: Introduction
729
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
729
Heart Failure VI: Adjunct Therapies
278
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
278
Heart Failure Drugs: Diuretics
825
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
825
Heart Failure V: Medical Management
227
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
227

